UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004507
Receipt No. R000005388
Scientific Title Pharmacogenomic analysis for Phase II clinical trial of the third-line Cetuximab and irinotecan or Cetuximab therapy for patients with KRAS wild type unresectable/recurrent colorectal cancer
Date of disclosure of the study information 2010/11/08
Last modified on 2018/10/31 22:39:11

No. Disposal Last modified on Item of update
1 Insert 2010/11/05 11:48:00
2 Update 2011/09/18 06:59:40 Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2011/09/18 06:59:58 Recruitment status
4 Update 2011/11/05 16:08:40 Recruitment status
5 Update 2012/05/07 10:18:29 Recruitment status
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2012/09/17 06:40:58 Recruitment status
7 Update 2018/10/31 22:39:11 Last name of lead principal investigator
Last name of lead principal investigator
TEL
Email
Last name of contact person
Last name of contact person
Address
Address
TEL
Name of primary sponsor
Organization
Category of Funding Organization


Contact us.